Hamas is battling to survive

Plus, the US Supreme Court may rule on birthright citizenship.

Global news you can trust. Download the Reuters App. Daily Briefing Daily Briefing By Kate Turton Hello. Hamas is battling to survive as it faces defiant clans and doubts over Iran. In the US, Republicans struggle to rewrite the tax bill, and a deal with Beijing will expedite rare earth exports from China. Plus, meet the Americans who make their own weight-loss drugs. Today's Top News   A general view of the US Supreme Court building in Washington. Picture taken November 26, 2021. REUTERS/Will Dunham/File photo The Supreme Court may rule on Donald Trump's attempt to broadly enforce his executive order to limit birthright citizenship, a move that would affect thousands of babies born each year. Senate Republicans were trying to reach consensus over Trump's sprawling tax-cut and spending bill, including proposed healthcare cuts that have worried some of their more populist-minded members. Politics Reporter David Morgan in Washington DC tells Reuters World News podcast about some of the hurdles that remain in their way. Listen now. Short of commanders, deprived of much of its tunnel network and unsure of support from its ally Iran, Hamas is battling to survive in Gaza in the face of rebellious local clans and relentless Israeli military pressure. US Defense Secretary Pete Hegseth said he was unaware of any intelligence suggesting Iran had moved any of its highly enriched uranium to shield it from US strikes, amid continuing questions about the state of Iran's nuclear program. Investigators have downloaded flight recorder data from an Air India crash this month that killed 260 people, India's civil aviation ministry said, a long-awaited step towards understanding the world's worst aviation disaster in a decade. For Trump, Vladimir Putin is a man looking for an off-ramp to his bloody three-year assault on Ukraine. But according to NATO Secretary General Mark Rutte, the Russian leader may be just getting started. Rutte warned Russia could attack an alliance country within three years. Hungarian Prime Minister Viktor Orban said there would be "legal consequences" for organising or attending a Budapest Pride march in violation of a police ban on the event planned for this weekend. Countries agreed to increase the U.N. climate body's budget by 10% for the next two years, a move the body welcomed as a commitment by governments to work together to address on climate change, with China's contribution rising. Business & Markets   Workers transport soil containing rare earth elements for export at a port in Lianyungang, Jiangsu province, China October 31, 2010. REUTERS/Stringer/File Photo The US has reached an agreement with China on how to expedite rare earth shipments to the US, a White House official said, amid efforts to end a trade war between the world's biggest economies. Germany has taken steps towards blocking Chinese AI startup DeepSeek from the Apple and Google app stores due to concerns about data protection, according to a data protection authority commissioner. Luxury goods retailers are shifting from a transactional model - where a shop merely sells goods to customers - to enticing customers with "experiences" that ultimately spur growth. Nike shares surged 10% in premarket trading as an encouraging forecast and plans to reduce China production for US-bound goods bolstered confidence in an ongoing turnaround effort at the sportswear giant. The Brussels Public Prosecutor's office said it had opened an investigation into potential money laundering activities at the Belgian unit of French payments processor Worldline. The gulf between where the Federal Reserve projects interest rates will be by the end of 2026 and the more aggressive cutting financial markets expect by then is partly due to the expectation that US central bank chief Jerome Powell will be replaced by somebody more dovish next year, investors said. Our graphics team did a deep dive on US doves and hawks.   For more, watch our daily rundown on financial markets. The Week Ahead Tuesday will see France's smoking ban come into effect, however, cafe outdoor terraces will be exempt. Central bankers meet for the ECB's annual forum in the foothills of Portugal's Sintra Mountains on Tuesday, with the focus on what rates-setters say on never-ending geopolitical turbulence. Thursday will see the release of the latest US jobs data, which will shed light on the health of the labour market. Read our round-up of the week ahead in financial markets. Stung by high prices, Americans make their own weight-loss drugs    Amy Spencer holds a vial containing the components of obesity drugs, which she purchased through the grey market, Missouri, April 24, 2025. REUTERS/Callaghan O'Hare In what she calls the "wild west" of obesity medicines, Missouri-based Amy Spencer is a pioneer. Each week the mother of two injects herself with weight-loss drugs, two of which are in clinical trials and not yet approved for sale by the US. Food and Drug Administration. One comes mixed with tirzepatide, the active ingredient in Eli Lilly's Zepbound. Spencer is not part of any drug trial but mixes the cocktails herself, using tiny doses that she believes are safe. The total cost is about $50 monthly, as little as one-tenth of what she would expect to pay their makers for full treatment. Read more Inside Track Global sports editor Ossian Shine launches a new weekly column exploring the stories, stakes and undercurrents shaping the weekend in sport. This week Wimbledon serves its first ace, soccer renews its awkward courtship with America, and Formula One's civil war simmers under the summer sun. Read more Get full access to Reuters.com for just $1/week. Subscribe now. Sponsors are not involved in the creation of newsletters or other Reuters news content. Advertise in this newsletter or on Reuters' website Reuters Daily Briefing is sent 5 days a week. Think your friend or colleague should know about us? Forward this newsletter to them. They can also sign up here. Want to stop receiving this email? Unsubscribe here. To manage which newsletters you're signed up for, click here. This email includes limited tracking for Reuters to understand whether you've engaged with its contents. For more information on how we process your personal information and your rights, please see our Privacy Statement. Terms & Conditions © 2025 Thomson Reuters. All rights reserved. 3 Times Square, New York, NY 10036